OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets
Garvit Satija, Barkha Sharma, Anish Madan, et al.
Journal of Heterocyclic Chemistry (2021) Vol. 59, Iss. 1, pp. 22-66
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies
Suman Adhikari, Priyatosh Nath, Alakesh Das, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116211-116211
Open Access | Times Cited: 49

Computational and electrochemistry of effective triazolyl-benzimidazolone inhibitors in aggressive environment
Rajae Salim, Mohamed Adardour, Walid Ettahiri, et al.
Sustainable materials and technologies (2024) Vol. 39, pp. e00862-e00862
Closed Access | Times Cited: 15

Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents: A Systematic Review
Maria Marinescu
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1220-1220
Open Access | Times Cited: 28

Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship
Keshav Taruneshwar Jha, Abhimannu Shome, Chahat, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106680-106680
Closed Access | Times Cited: 26

Recent advances of benzimidazole as anticancer agents
Sneha Venugopal, Balwinder Kaur, Anil Verma, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 2, pp. 357-376
Closed Access | Times Cited: 23

Structure–Activity Relationships in NHC–Silver Complexes as Antimicrobial Agents
Luisa Ronga, Mario Varcamonti, Diego Tesauro
Molecules (2023) Vol. 28, Iss. 11, pp. 4435-4435
Open Access | Times Cited: 20

Magnetic nanomaterials as green and recoverable nanocatalysts: Research on synthesis of benzimidazole derivatives
Khalid Mujasam Batoo, Mohammed Kadhem Abid, Abdul-Hameed M. Hamoody, et al.
Synthetic Communications (2024) Vol. 54, Iss. 9, pp. 709-734
Closed Access | Times Cited: 6

Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article
Nardin Wagih, Islam M. Abdel-Rahman, Nawal El‐Koussi, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 966-1010
Open Access

The literature of heterocyclic chemistry, part XXII, 2022
Галина А. Газиева, Yu. B. Evdokimenkova, N. O. Soboleva
Advances in heterocyclic chemistry (2025)
Closed Access

Exploration of Remarkably Potential Multitarget-Directed N-Alkylated-2-(substituted phenyl)-1H-benzimidazole Derivatives as Antiproliferative, Antifungal, and Antibacterial Agents
Ngoc‐Kim‐Ngan Phan, Thi‐Kim‐Chi Huynh, Hoang-Phuc Nguyen, et al.
ACS Omega (2023) Vol. 8, Iss. 31, pp. 28733-28748
Open Access | Times Cited: 14

Recent Advances in the Anticancer Applications of Benzimidazole Derivatives
Mohammad Mavvaji, Senem Akkoç
ChemistrySelect (2023) Vol. 8, Iss. 35
Closed Access | Times Cited: 12

Design, Synthesis, Docking Study, and Antiproliferative Evaluation of Novel Schiff Base–Benzimidazole Hybrids with VEGFR-2 Inhibitory Activity
Hany M. Abd El‐Lateef, Mohammed A. I. Elbastawesy, Tamer Mohamed Abdelghani Ibrahim, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 481-481
Open Access | Times Cited: 11

Synthesis, Cytotoxic Activity Evaluation and Molecular Docking Studies of Some Benzimidazole Derivatives
Aybüke Züleyha Kaya, Derya Osmani̇ye, Asaf Evrim Evren, et al.
Cumhuriyet Science Journal (2024) Vol. 45, Iss. 1, pp. 80-87
Open Access | Times Cited: 3

Synthesis and characterization of new purple and green heterocyclic dyes for dye-sensitized solar cells
Mehrdad Mazrouei, Mehdi Pordel, Abolghasem Davoodnia, et al.
Journal of Molecular Structure (2024) Vol. 1315, pp. 138814-138814
Closed Access | Times Cited: 3

Antimicrobial and antibiofilm activities and bovine serum albumin binding properties of benzimidazolium derivative NHC salts and their Ag(I)‐NHC complexes
Cem Çeli̇k, Elvan Üstün, Neslihan Şahin, et al.
Applied Organometallic Chemistry (2022) Vol. 36, Iss. 12
Closed Access | Times Cited: 19

New Potential Agents for Malignant Melanoma Treatment—Most Recent Studies 2020–2022
Paweł Kozyra, Danuta Krasowska, Monika Pitucha
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6084-6084
Open Access | Times Cited: 16

Acetylcholine Inhibitory Study of Novel Thio Linked Coumarin-Benzimidazole Derivatives: Design, Synthesis, Computational, and In Silico Molecular Docking Studies
T. H. Maruthi Nayaka, Itte Pushpavathi, P Pavithra, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 1, pp. 211-226
Closed Access | Times Cited: 2

Diaryl-substituted benzimidazole derivatives as antiproliferative agents: Design, synthesis, in vitro activity, and SAR analysis
Şule Gürsoy, Ronak Haj Ersan
Journal of Molecular Structure (2024) Vol. 1308, pp. 137960-137960
Closed Access | Times Cited: 2

Environmentally friendly and efficient TBHP-mediated catalytic reaction for the synthesis of substituted benzimidazole-2-ones: approach to pharmaceutical applications
Meeniga Indira, E.C. Surendranath Reddy, V. Kamala Prasad, et al.
Environmental Research (2024) Vol. 252, pp. 118760-118760
Closed Access | Times Cited: 2

pH-tailored delivery of a multitarget anticancer benzimidazole derivative using a PEGylated β-cyclodextrin-curcumin functionalized nanocomplex
Heba Shawky, Dalia B. Fayed, Noha E. Ibrahim
Biomaterials Advances (2024) Vol. 163, pp. 213964-213964
Closed Access | Times Cited: 2

Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemia
Hend A. A. Ezelarab, Taha F. S. Ali, Samar H. Abbas, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 7

Advances of Benzimidazole Derivatives as Anticancer Agents: Bench to Bedside
Kashif Haider, Mohammad Shahar Yar
Biochemistry (2022)
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top